Amicus Therapeutics Total Assets 2007-2019 | FOLD

Amicus Therapeutics total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Amicus Therapeutics Annual Total Assets
(Millions of US $)
2018 $790
2017 $627
2016 $1,037
2015 $908
2014 $210
2013 $128
2012 $110
2011 $70
2010 $113
2009 $85
2008 $129
2007 $167
2006 $60
2005 $0
Amicus Therapeutics Quarterly Total Assets
(Millions of US $)
Q1 2019 $765
Q4 2018 $790
Q3 2018 $839
Q2 2018 $826
Q1 2018 $870
Q4 2017 $627
Q3 2017 $681
Q2 2017 $939
Q1 2017 $993
Q4 2016 $1,037
Q3 2016 $918
Q2 2016 $914
Q1 2016 $863
Q4 2015 $908
Q3 2015 $987
Q2 2015 $404
Q1 2015 $193
Q4 2014 $210
Q3 2014 $125
Q2 2014 $118
Q1 2014 $112
Q4 2013 $128
Q3 2013 $69
Q2 2013 $82
Q1 2013 $93
Q4 2012 $110
Q3 2012 $118
Q2 2012 $112
Q1 2012 $121
Q4 2011 $70
Q3 2011 $79
Q2 2011 $90
Q1 2011 $103
Q4 2010 $113
Q3 2010 $64
Q2 2010 $75
Q1 2010 $88
Q4 2009 $85
Q3 2009 $99
Q2 2009 $109
Q1 2009 $116
Q4 2008 $129
Q3 2008 $143
Q2 2008 $151
Q1 2008 $160
Q4 2007 $167
Q3 2007 $125
Q2 2007 $132
Q1 2007 $0
Q3 2006 $0
Q2 2006 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.729B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $102.707B 11.61
Gilead Sciences (GILD) United States $83.965B 10.19
Celgene (CELG) United States $66.880B 11.33
Biogen (BIIB) United States $44.743B 8.49
Illumina (ILMN) United States $44.187B 51.21
Vertex Pharmaceuticals (VRTX) United States $42.447B 51.31
Regeneron Pharmaceuticals (REGN) United States $33.064B 15.54
Alexion Pharmaceuticals (ALXN) United States $28.530B 16.15
Incyte (INCY) United States $16.475B 66.81
BioMarin Pharmaceutical (BMRN) United States $15.518B 0.00
Exact Sciences (EXAS) United States $12.402B 0.00
Seattle Genetics (SGEN) United States $10.385B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
Sarepta Therapeutics (SRPT) United States $8.718B 0.00
QIAGEN (QGEN) Netherlands $8.572B 28.16
Bio-Techne Corp (TECH) United States $7.478B 51.02
Moderna (MRNA) United States $7.436B 0.00
BeiGene (BGNE) Cayman Islands $7.405B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.017B 0.00
Guardant Health (GH) United States $6.818B 0.00
Bluebird Bio (BLUE) United States $6.696B 0.00
Exelixis (EXEL) United States $5.918B 15.09
Galapagos (GLPG) Belgium $5.771B 0.00
Amarin (AMRN) Ireland $5.435B 0.00
Ascendis Pharma (ASND) Denmark $5.231B 0.00
Array BioPharma (ARRY) United States $4.648B 0.00
Spark Therapeutics (ONCE) United States $4.136B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.089B 0.00
Alkermes (ALKS) Ireland $3.850B 0.00
Blueprint Medicines (BPMC) United States $3.707B 0.00
China Biologic Products (CBPO) China $3.622B 23.00
ACADIA Pharmaceuticals (ACAD) United States $3.493B 0.00
Allogene Therapeutics (ALLO) United States $3.436B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.364B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.297B 0.00
Global Blood Therapeutics (GBT) United States $3.201B 0.00
Repligen (RGEN) United States $3.176B 79.13
Immunomedics (IMMU) United States $2.957B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.739B 0.00
Reata Pharmaceuticals (RETA) United States $2.690B 0.00
Arena Pharmaceuticals (ARNA) United States $2.652B 5.39
Mirati Therapeutics (MRTX) United States $2.550B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.530B 0.00
Medicines (MDCO) United States $2.530B 0.00
UniQure (QURE) Netherlands $2.309B 0.00
MyoKardia (MYOK) United States $2.275B 0.00
Emergent Biosolutions (EBS) United States $2.226B 19.33
Halozyme Therapeutics (HALO) United States $2.216B 0.00
Ligand Pharmaceuticals (LGND) United States $2.214B 18.34
NeoGenomics (NEO) United States $2.211B 144.94
Insmed (INSM) United States $2.180B 0.00
Acceleron Pharma (XLRN) United States $2.161B 0.00
Genomic Health (GHDX) United States $2.025B 43.01
CRISPR Therapeutics AG (CRSP) Switzerland $1.994B 0.00
Denali Therapeutics (DNLI) United States $1.967B 0.00
Lion Biotechnologies (IOVA) United States $1.928B 0.00
Allakos (ALLK) United States $1.863B 0.00
AnaptysBio (ANAB) United States $1.852B 0.00
Myriad Genetics (MYGN) United States $1.849B 18.39
Akcea Therapeutics (AKCA) United States $1.848B 0.00
Audentes Therapeutics (BOLD) United States $1.718B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.666B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.594B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.563B 0.00
REGENXBIO (RGNX) United States $1.539B 0.00
Innoviva (INVA) United States $1.439B 3.98
Cambrex (CBM) United States $1.426B 18.03
Gossamer Bio (GOSS) United States $1.360B 0.00
Alector (ALEC) United States $1.351B 0.00
Coherus BioSciences (CHRS) United States $1.321B 0.00
Rubius Therapeutics (RUBY) United States $1.310B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.260B 0.00
Aimmune Therapeutics (AIMT) United States $1.228B 0.00
Fate Therapeutics (FATE) United States $1.202B 0.00
Apellis Pharmaceuticals (APLS) United States $1.165B 0.00
Sangamo Therapeutics (SGMO) United States $1.128B 0.00
Atara Biotherapeutics (ATRA) United States $1.087B 0.00
Editas Medicine (EDIT) United States $1.056B 0.00
Epizyme (EPZM) United States $1.038B 0.00
Codexis (CDXS) United States $1.022B 0.00
InflaRx (IFRX) Germany $0.997B 0.00
Eidos Therapeutics (EIDX) United States $0.984B 0.00
RA PHARMCTL INC (RARX) United States $0.955B 0.00
Athenex (ATNX) United States $0.936B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.920B 0.00
Myovant Sciences (MYOV) United Kingdom $0.887B 0.00
NGM Biopharmaceuticals (NGM) United States $0.885B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.884B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.883B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.875B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.873B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.868B 0.00
Clovis Oncology (CLVS) United States $0.867B 0.00
WAVE Life Sciences (WVE) Singapore $0.854B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.847B 0.00
G1 THERAPEUTICS (GTHX) United States $0.845B 0.00
ANI Pharmaceuticals (ANIP) United States $0.834B 14.80
Dicerna Pharmaceuticals (DRNA) United States $0.814B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.790B 37.28
MeiraGTx Holdings (MGTX) United States $0.781B 0.00
Cellectis (CLLS) France $0.761B 0.00
Axsome Therapeutics (AXSM) United States $0.756B 0.00
Retrophin (RTRX) United States $0.755B 0.00
Principia Biopharma (PRNB) United States $0.755B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.742B 0.00
Cara Therapeutics (CARA) United States $0.724B 0.00
Arvinas (ARVN) United States $0.720B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.715B 0.00
Twist Bioscience (TWST) United States $0.709B 0.00
Vericel (VCEL) United States $0.701B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.684B 0.00
CORTEXYME INC (CRTX) United States $0.679B 0.00
Intra-Cellular Therapies (ITCI) United States $0.677B 0.00
Precision BioSciences (DTIL) United States $0.664B 0.00
Stemline Therapeutics (STML) United States $0.625B 0.00
Zealand Pharma (ZEAL) Denmark $0.624B 7.29
Lexicon Pharmaceuticals (LXRX) United States $0.619B 0.00
Cytokineticsorporated (CYTK) United States $0.604B 0.00
Puma Biotechnology (PBYI) United States $0.604B 0.00
Heska (HSKA) United States $0.603B 61.78
Kura Oncology (KURA) United States $0.601B 0.00
Viking Therapeutics (VKTX) United States $0.593B 0.00
Zymeworks (ZYME) Canada $0.591B 0.00
ObsEva SA (OBSV) Switzerland $0.578B 0.00
Adverum Biotechnologies (ADVM) United States $0.564B 0.00
Magenta Therapeutics (MGTA) United States $0.562B 0.00
Kaleido Biosciences (KLDO) $0.540B 0.00
Scholar Rock Holding (SRRK) United States $0.539B 0.00
DBV Technologies (DBVT) France $0.533B 0.00
Anika Therapeutics (ANIK) United States $0.528B 18.05
Revance Therapeutics (RVNC) United States $0.522B 0.00
Acorda Therapeutics (ACOR) United States $0.518B 9.12
UROGEN PHARMA (URGN) United States $0.512B 0.00
Synthorx (THOR) United States $0.510B 0.00
CytomX Therapeutics (CTMX) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.485B 0.00
Krystal Biotech (KRYS) United States $0.465B 0.00
Replimune (REPL) United States $0.460B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.458B 0.00
MediciNova (MNOV) United States $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.454B 0.00
NEXTCURE INC (NXTC) United States $0.453B 0.00
MILESTONE PHARM (MIST) Canada $0.450B 0.00
Sorrento Therapeutics (SRNE) United States $0.440B 0.00
AVROBIO (AVRO) United States $0.433B 0.00
Arcus Biosciences (RCUS) United States $0.429B 0.00
Albireo Pharma (ALBO) United States $0.429B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.406B 0.00
Cyclerion Therapeutics (CYCN) United States $0.403B 0.00
BioDelivery Sciences (BDSI) United States $0.395B 0.00
Senesco Technologies (ELOX) United States $0.394B 0.00
Dynavax Technologies (DVAX) United States $0.392B 0.00
Gritstone Oncology (GRTS) United States $0.391B 0.00
Agenus (AGEN) United States $0.389B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.379B 0.00
Kezar Life Sciences (KZR) United States $0.376B 0.00
UNITY Biotechnology (UBX) $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.370B 0.00
Prothena (PRTA) Ireland $0.370B 0.00
Abeona Therapeutics (ABEO) United States $0.361B 0.00
PDL BioPharma (PDLI) United States $0.360B 8.51
BeyondSpring (BYSI) United States $0.348B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.340B 0.00
LogicBio Therapeutics (LOGC) United States $0.332B 0.00
AC Immune SA (ACIU) Switzerland $0.330B 21.26
Biofrontera AG Sponsored ADR (BFRA) Germany $0.328B 0.00
Kindred Biosciences (KIN) United States $0.328B 0.00
Kodiak Sciences (KOD) United States $0.327B 0.00
Inovio Pharmaceuticals (INO) United States $0.324B 0.00
AXCELLA HEALTH (AXLA) United States $0.323B 0.00
XBiotech (XBIT) United States $0.323B 0.00
Five Prime Therapeutics (FPRX) United States $0.318B 0.00
Palatin Technologies (PTN) United States $0.315B 0.00
Merus (MRUS) Netherlands $0.309B 0.00
HOOKIPA PHARMA (HOOK) United States $0.308B 0.00
Cellular Biomedicine (CBMG) United States $0.302B 0.00
ResTORbio (TORC) United States $0.290B 0.00
Geron (GERN) United States $0.287B 0.00
Kadmon Holdings (KDMN) United States $0.286B 0.00
Athersys (ATHX) United States $0.279B 0.00
PHASEBIO PHARMA (PHAS) United States $0.260B 0.00
Aduro Biotech (ADRO) United States $0.259B 0.00
Evelo Biosciences (EVLO) United States $0.253B 0.00
Urovant Sciences (UROV) United States $0.252B 0.00
Protagonist Therapeutics (PTGX) United States $0.248B 0.00
ChromaDex (CDXC) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.239B 0.00
MannKind (MNKD) United States $0.238B 0.00
Celcuity (CELC) United States $0.238B 0.00
Constellation Pharmaceuticals (CNST) United States $0.233B 0.00
Syros Pharmaceuticals (SYRS) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.232B 0.00
Mersana Therapeutics (MRSN) United States $0.228B 0.00
Kamada (KMDA) Israel $0.227B 8.83
Cerecor (CERC) United States $0.227B 0.00
Pfenex (PFNX) United States $0.225B 0.00
OvaScience (MLND) United States $0.218B 0.00
Enochian BioSciences (ENOB) United States $0.218B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.215B 0.00
TOCAGEN INC (TOCA) United States $0.214B 0.00
Arsanis (XFOR) United States $0.211B 0.00
Affimed (AFMD) Germany $0.208B 0.00
Spero Therapeutics (SPRO) United States $0.207B 0.00
Solid Biosciences (SLDB) United States $0.206B 0.00
Synlogic (SYBX) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.197B 0.00
Kala Pharmaceuticals (KALA) United States $0.196B 0.00
Avid Bioservices (CDMO) United States $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.194B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.194B 0.00
Chiasma (CHMA) United States $0.193B 0.00
Neothetics (EVFM) United States $0.189B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.188B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
Celyad SA (CYAD) Belgium $0.187B 0.00
Liquidia Technologies (LQDA) United States $0.186B 0.00
Cue Biopharma (CUE) United States $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Compugen (CGEN) Israel $0.177B 0.00
Cel-Sci (CVM) United States $0.177B 0.00
Seres Therapeutics (MCRB) United States $0.173B 0.00
Gamida Cell (GMDA) Israel $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.172B 0.00
Enzo Biochem (ENZ) United States $0.171B 0.00
BioTime (BTX) United States $0.169B 11.30
Intec Pharma (NTEC) Israel $0.169B 0.00
CorMedix Inc (CRMD) United States $0.168B 0.00
Axovant Sciences (AXGT) United Kingdom $0.168B 0.00
Anavex Life Sciences (AVXL) United States $0.168B 0.00
Menlo Therapeutics (MNLO) United States $0.165B 0.00
TREVI THERAPTCS (TRVI) United States $0.160B 0.00
Strongbridge Biopharma (SBBP) United States $0.159B 9.16
Checkpoint Therapeutics (CKPT) United States $0.158B 0.00
Mustang Bio (MBIO) United States $0.156B 0.00
XOMA (XOMA) United States $0.143B 0.00
Provention Bio (PRVB) United States $0.142B 0.00
Novavax (NVAX) United States $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.137B 0.00
SESEN BIO, INC (SESN) United States $0.136B 0.00
Arbutus Biopharma (ABUS) Canada $0.134B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.133B 0.00
OSMOTICA PHARM (OSMT) United States $0.132B 0.00
Fortress Biotech (FBIO) United States $0.125B 0.00
VolitionRX (VNRX) Singapore $0.124B 0.00
Trevena (TRVN) United States $0.121B 0.00
Organovo Holdings (ONVO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.115B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.115B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.114B 0.00
Equillium (EQ) United States $0.114B 0.00
Verastem (VSTM) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Aptinyx (APTX) United States $0.113B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.109B 0.00
Allena Pharmaceuticals (ALNA) United States $0.105B 0.00
Unum Therapeutics (UMRX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.104B 0.00
NantKwest (NK) United States $0.104B 0.00
Selecta Biosciences (SELB) United States $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.099B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.098B 0.00
INmune Bio (INMB) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.096B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.089B 0.00
Signal Genetics (MGEN) United States $0.087B 0.00
Cohbar (CWBR) United States $0.086B 0.00
Aptose Biosciences (APTO) Canada $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 83.33
VTv Therapeutics (VTVT) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.60
Alimera Sciences (ALIM) United States $0.067B 0.00
OVID THERAPEUTC (OVID) United States $0.067B 0.00
Alcobra (ARCT) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
Apricus Biosciences (SEEL) United States $0.057B 0.00
Ophthotech (ISEE) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
Cidara Therapeutics (CDTX) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
AZURRX BIOPHARM (AZRX) United States $0.052B 0.00
Moleculin Biotech (MBRX) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Hoth Therapeutics (HOTH) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.043B 0.00
VIVUS (VVUS) United States $0.043B 0.00
Celsion (CLSN) United States $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.042B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.039B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.038B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Leap Therapeutics (LPTX) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Oragenics (OGEN) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
GTx (GTXI) United States $0.025B 0.00
OncoSec Medical (ONCS) United States $0.024B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
TRACON Pharmaceuticals (TCON) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Adial Pharmaceuticals (ADIL) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.020B 0.00
Galena Biopharma (SLS) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
IMMURON LTD (IMRN) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Advaxis (ADXS) United States $0.017B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Therapix Biosciences (TRPX) Israel $0.011B 5.65
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Dare Bioscience (DARE) United States $0.011B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
BioPharmX (BPMX) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Alliqua BioMedical (ADYX) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.002B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00